Autoimmune hepatitis quietly damages the liver for years before symptoms appear; specialists in Kenya warn of late diagnoses and urge early medical checks. [File, Standard] When people think about ...

The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible.

Background Primary biliary cholangitis (PBC) is a rare autoimmune liver disease that can progress to fibrosis and cirrhosis. As molecular biomarkers for PBC remain limited, we performed integrated ...

A systematic review found that patients with autoimmune liver diseases had altered oral microbiota — notably increased Veillonella — which in some studies was associated with elevated salivary ...

A type of rare T cell triggers a cascade of signals amplifying inflammation and ultimately leading to liver fibrosis, according to a new study from Julius Maximilian University of Würzburg published ...

—A recent study provides genetic evidence linking a higher body mass index (BMI) to an increased risk of primary biliary cholangitis and autoimmune hepatitis but a decreased risk of primary sclerosing ...

Alfasigma, a global pharmaceutical company, today announced that five presentations on linerixibat in primary biliary cholangitis (PBC), including one oral presentation and four posters, will be ...

Autoimmune liver diseases encompass a spectrum of chronic inflammatory conditions in which the body’s immune system targets hepatic cells or bile ducts. The principal entities are autoimmune hepatitis ...

Liver disease affects 1.8% of US adults, with significant mortality due to cirrhosis complications. Causes include viral infections, autoimmune disorders, genetic factors, and lifestyle choices like ...

The prevalence of type 2 diabetes in patients with autoimmune liver disease was 27.6%. Type 2 diabetes seems to reduce the risk of primary sclerosing cholangitis (PSC), and primary biliary cholangitis ...

The prevalence of AILD and IBD supports the gut-liver axis theory. Inflammatory bowel disease (IBD) and autoimmune liver disease (AILD) prevalence are significantly correlated, according to a study in ...